BioNxt Solutions ( ($TSE:BNXT) ) has provided an announcement. BioNxt Solutions Inc. has received a ‘Readiness to Grant’ notification from the ...

BioNxt Solutions ( ($TSE:BNXT) ) has shared an update. BioNxt Solutions Inc. has received an ‘Intention to Grant’ notification from the European ...

Changes strategically aligned to support planned launch of Anaphylm™ (dibutepinephrine) Sublingual Film, if approved by the FDA, and to ...

A man taking warfarin presents with blood-stained saliva and swelling that rapidly progresses to airway obstruction, ...

BioNxt Solutions Inc. (“BioNxt” or the “Company”) (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in ...

Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science ...

Bionxt launched the final animal study needed to prepare for human testing of BNT23001, its under-the-tongue version of ...

Tonmya demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT studyTreatment was well tolerated ...

BioNxt Solutions Inc. (CSE:BNXT) (OTCQB:BNXTF) (FSE:BXT), a bioscience company developing next-generation drug delivery technologies, has launched a 15-day dosing optimization study for its lead ...

LOS ANGELES — The woes were difficult to ignore. The results were even worse. Since 2018, the start of the Chip Kelly era, UCLA football had allowed 450 or more yards and 250 rushing yards at home on ...

Anthropic released Claude Haiku 4.5 on Wednesday, a smaller and significantly cheaper artificial intelligence model that matches the coding capabilities of systems that were considered cutting-edge ...

President Donald Trump refused to take a question from an ABC correspondent on Tuesday, blasting the network over This Week host George Stephanopoulos‘ contentious interview with JD Vance on Sunday.